Abstract We developed and benchmarked Exome Cancer Test v.2.0 (EXaCT-2), a novel whole-exome sequencing (WES) assay based on Agilent’s SureSelect hybrid-capture technology and expanded with custom probes targeting cancer-informative genomic regions.
Wayne Tam
New York
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Wayne Tam
Concordance Between Fragment Analysis and Next-Generation Sequencing in Identification of Non-Standard CALR Indels
J. L. G.Marti, N.Seth, A.Bendari, et al., “Concordance Between Fragment Analysis and Next-Generation Sequencing in Identification of Non-Standard CALR Indels,” International Journal of Laboratory Hematology (2026): 1–9, https://doi.org/10.1111/ijlh.70093. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that supports the findings of this study are available in the of this article.
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking
Abstract Background: Although advance has been made in understanding the pathogenesis of mature T-cell neoplasms, the initiation and progression of angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), remain poorly understood. A subset of AITL/PTCL-NOS patients develop concomitant hematologic neoplasms (CHN), and a biomarker to predict this risk is lacking.
"Myeloid/Lymphoid Neoplasms with FLT3 Rearrangement" by Guilin Tang, Wayne Tam et al.
Abstract Myeloid/lymphoid neoplasms (M/LN) with 13q12/FLT3 rearrangement have been suggested as candidates for possible inclusion in the World Health Organization classification group of M/LN with eosinophilia (M/LN-eo). We report 12 patients with confirmed FLT3 rearrangement, six with t(12;13)/ETV6-FLT3; one with ins(13;22)/BCR-FLT3; and five with an unconfirmed partner gene located on chromosome bands 2p16, 3q27, 5q15, 5q35, and 7q36.
Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma
Fig. 1: Mutation and clonal evolution analyses of 4 cases of TdT+ lymphoblastic tumors (TdT-LBT). Fig. 2: Model of B-lymphoblastic transformation of FL. References 1. Fischer T, Zing NPC, Chiattone CS, Federico M, Luminari S. Transformed follicular lymphoma. Ann Hematol. 2018;97(Jan):17–29. CAS Article Google Scholar 2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(May):2375–90.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Wayne
Contact Wayne, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack